UConn School of Medicine has named Riqiang Yan, Ph.D. an expert on Alzheimer’s disease, as chairman of the neuroscience department.
Yan, who comes from the Cleveland Clinic, will establish the medical school’s first research laboratory dedicated to studying and potentially discovering new treatments for Alzheimer’s and other forms of neurodegenerative disease.
Yan is “an internationally recognized neurodegenerative disease researcher specializing in identifying the biological culprits behind Alzheimer’s disease,” an announcement from UConn said. He has five studies funded by the National Institutes of Health.
“We welcome Dr. Yan to UConn School of Medicine and Connecticut as he and his research programs are very highly respected by leaders and other scientists in the field,” said Bruce T. Liang, dean of UConn School of Medicine.
Yan currently serves as the Cleveland Clinic’s Morris R. and Ruth V. Graham Endowed Chair Professor and Vice Chair of Neurosciences and professor of molecular medicine at Case Western Reserve University.
He received his Ph.D. from the University of Kentucky and completed a postdoctoral fellowship at The Rockefeller University.
“I am very excited to join UConn,” Yan said. “I see a new chapter ahead and an opportunity for UConn School of Medicine’s Department of Neuroscience to truly shine brighter.”
Yan added: “We all have a hope that in five to 10 years with academia collaborating with pharmaceutical companies we will indeed have an effective drug to finally treat Alzheimer’s disease.”